Which Pharma stocks should you buy now?

Now that vaccinations are almost off the front page, here are seven of the best pharma stocks to buy now. While 97% of its sales are in the U.S., HZNP is one of those pharmaceuticals that moved its operations to Ireland for favorable tax status. With a $20 billion market cap, it’s one of the biggest pharma stocks on our list.

Are Pharma stocks ripe for investment?

Nevertheless, pharma stocks with strong fundamentals and growth potential are ripe for investment. It’s an ideal time for investors to take advantage of the resurgence of value stocks and pile into undervalued pharma stocks. Major drug and pharma companies have outperformed the S&P 500 in five calendar years since 2005.

Are Pharma stocks a safe bet on the trillion-dollar industry?

The global pharma industry is set to grow by 3% to 6% per year and be worth over $1.5 trillion by 2023, according to research from Reportlinker. Let's look at why these stocks are a safe bet on the trillion-dollar industry. Image source: Getty Images. 1. Regeneron The sky is truly the limit for Regeneron Pharmaceuticals ( REGN 0.15%).

Should you buy pharmaceutical stocks with dividend yields of 2%?

Active investing with SoFi makes it easy to start investing in stocks and ETFs. Here are seven Morningstar-recommended pharmaceutical stocks to buy with forward dividend yields of at least 2%: Roche is a Swiss pharmaceuticals and diagnostics company. Its leading products include cancer drugs Avastin, Herceptin and Rituxan.